Temple University

Running trials

• Not yet recruiting

  The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease

  NCT07907991· Phase 3· Source

• Not yet recruiting

  Pilot Trial Utilizing β-hydroxy-β-methylbutyrate to Lower IGFBP7 Levels in People With ALS

  NCT07589764· Phase 1· Source

• Not yet recruiting

  Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis

  NCT07674745· Phase 2· Source

• Not yet recruiting

  LAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)

  NCT07886554· Phase 2· Source

• Not yet recruiting

  Testing a Mobile Health Application to Improve HIV Prevention and Substance Use Treatment Among Women Involved in the Carceral System

  NCT07432555· Source

• Not yet recruiting

  Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

  NCT07520110· Phase 3· Source

• Not yet recruiting

  Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3

  NCT06182475· Source

• Recruiting

  Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  NCT07059091· Phase 2· Source

• Active, not recruiting

  A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

  NCT07036523· Phase 2· Source

• Recruiting

  A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  NCT07175038· Phase 2· Source

• Recruiting

  Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

  NCT06891755· Source

• Recruiting

  STimulation to Activate RespIration

  NCT06832306· Source

• Active, not recruiting

  Improving Participation in Universal School Meals (USM)

  NCT06579079· Source

• Active, not recruiting

  VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

  NCT06249165· Phase 4· Source

• Active, not recruiting

  A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

  NCT06643481· Phase 2· Source

• Active, not recruiting

  A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  NCT06238622· Phase 3· Source

• Recruiting

  Taking Action for College Students

  NCT06700902· Source

• Active, not recruiting

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· Phase 3· Source

• Active, not recruiting

  A Study to Evaluate Solrikitug in Participants With COPD (ZION)

  NCT06496620· Phase 2· Source

• Recruiting

  ASSESS ALL ALS Study

  NCT06578195· Source

• Active, not recruiting

  PREVENT ALL ALS Study

  NCT06581861· Source

• Recruiting

  RemI for Post-Bariatric Surgery Weight Regain

  NCT06292936· Source

• Active, not recruiting

  A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

  NCT06329401· Phase 2· Source

• Recruiting

  An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

  NCT06035120· Source

• Active, not recruiting

  Getting Out of the House: Using Behavioral Activation to Increase Community Participation

  NCT06336616· Source

• Recruiting

  Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  NCT06122077· Source

• Active, not recruiting

  To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

  NCT05908084· Phase 3· Source

• Active, not recruiting

  Assessment of Combined CCM and ICD Device in HFrEF

  NCT05855135· Source

• Active, not recruiting

  Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)

  NCT05382208· Phase 2· Source

• Active, not recruiting

  LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321420· Phase 2· Source

• Active, not recruiting

  AMP SCZ® Observational Study: PREDICT-DPACC

  NCT05905003· Source

• Recruiting

  Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

  NCT05642182· Phase 1· Source

• Recruiting

  myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

  NCT05204888· Source

• Recruiting

  STRIVE Post-Market Registry Study

  NCT04302272· Source

• Recruiting

  SPIROMICS Study of Early COPD Progression (SOURCE)

  NCT05033990· Source

• Active, not recruiting

  DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers

  NCT04165564· Source

• Active, not recruiting

  Detection of Early Idiopathic Pulmonary Fibrosis

  NCT03457935· Source

• Active, not recruiting

  Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

  NCT03315910· Phase 4· Source

• Active, not recruiting

  Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts

  NCT02181257· Phase 3· Source

• Recruiting

  Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  NCT01915511· Source

• Active, not recruiting

  Study of COPD Subgroups and Biomarkers

  NCT01969344· Source

• Enrolling by invitation

  Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center

  NCT01016613· Source

• Active, not recruiting

  Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)

  NCT00608764· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD8 recruiting
• Idiopathic pulmonary fibrosis3 recruiting
• ALS (motor neurone disease)2 recruiting
• Chronic kidney disease2 recruiting
• High blood pressure2 recruiting
• Pulmonary arterial hypertension2 recruiting
• Bipolar disorder1 recruiting
• Depression1 recruiting
• HIV1 recruiting
• Lung cancer1 recruiting
• Obesity1 recruiting
• Psoriasis1 recruiting
• Schizophrenia1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT06335303· Phase 2· Source

• Completed

  ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments

  NCT06429059· Phase 2· Source

• Completed

  Food for Thought: Executive Functioning Around Eating Among Children

  NCT06108128· Source

• Completed

  Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

  NCT05195918· Phase 1· Source

• Terminated

  Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC

  NCT05583188· Phase 4· Source

• Completed

  Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

  NCT05185089· Phase 2· Source

• Completed

  A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)

  NCT04813926· Source

• Completed

  Improving Everyday Task Performance Through Repeated Practice in Virtual Reality.

  NCT04315337· Source

• Completed

  Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial

  NCT04300920· Phase 3· Source

• Completed

  Prevention of Colorectal Cancer Through Multiomics Blood Testing

  NCT04369053· Source

• Completed

  Medication Adherence With Telehealthcare Medication Therapy Management

  NCT03978936· Source

• Completed

  Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency

  NCT03679598· Phase 2· Source

• Completed

  Light Treatment Effectiveness (LITE) Study

  NCT03726489· Source

• Completed

  A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

  NCT03626688· Phase 3· Source

• Completed

  Partnering With WIC to Prevent Excessive Weight Gain in Pregnancy

  NCT03707834· Source

• Completed

  Black Men's Care, and Intervention to Re-Engage HIV+ Black Men in Care

  NCT03579251· Source